Home In vitro biological activity of Hydroclathrus clathratus and its use as an extracellular bioreductant for silver nanoparticle formation
Article Open Access

In vitro biological activity of Hydroclathrus clathratus and its use as an extracellular bioreductant for silver nanoparticle formation

  • Raghad R. Alzahrani EMAIL logo , Manal M. Alkhulaifi EMAIL logo and Nouf M. Al-Enazi
Published/Copyright: August 7, 2020
Become an author with De Gruyter Brill

Abstract

The adaptive nature of algae results in producing unique chemical components that are gaining attention due to their efficiency in many fields and abundance. In this study, we screened the phytochemicals from the brown alga Hydroclathrus clathratus and tested its ability to produce silver nanoparticles (AgNPs) extracellularly for the first time. Lastly, we investigated its biological activity against a variety of bacteria. The biosynthesized nanoparticles were characterized by UV-visible spectroscopy, Fourier-transform infrared spectroscopy, dynamic light scattering, transmission electron microscopy, and energy-dispersive spectroscopy. The biological efficacy of AgNPs was tested against eighteen different bacteria, including seven multidrug-resistant bacteria. Phytochemical screening of the alga revealed the presence of saturated and unsaturated fatty acids, sugars, carboxylic acid derivatives, triterpenoids, steroids, and other components. Formed AgNPs were stable and ranged in size between 7 and 83 nm and presented a variety of shapes. Acinetobacter baumannii, Staphylococcus aureus, Methicillin-resistant S. aureus (MRSA), and MDR A. baumannii were the most affected among the bacteria. The biofilm formation and development assay presented a noteworthy activity against MRSA, with an inhibition percentage of 99%. Acknowledging the future of nano-antibiotics encourages scientists to explore and enhance their potency, notably if they were obtained using green, rapid, and efficient methods.

Abbreviations

AgNPs

silver nanoparticles

AgNPCB

silver nanoparticles synthesized by H. clathratus crude methanol extract

AgNPQB

silver nanoparticles synthesized by H. clathratus aqueous solution

ATCC

American Type Culture Collection

DLS

dynamic light scattering

DMSO

dimethyl sulfoxide

EDS

energy-dispersive spectroscopy

FTIR

Fourier-transform infrared spectroscopy

TEM

transmission electron microscopy

1 Introduction

Despite the progress of bacterial resistance to antibiotics, the development of a new, effective antibiotic against multidrug-resistant (MDR) bacteria has been progressing at a slow pace. Recent studies have suggested using nanotechnology as a promising strategy to challenge bacterial resistance to antibiotics using natural constituents as reducing agents to synthesize nanoparticles (NPs), although this approach could be limited due to the toxicity and unpredictability of NPs [1]. There were several cases that reported the existence of MDR bacteria in Saudi Arabia. For example, a few cases of MDR tuberculosis in different regions of Saudi Arabia were observed [2]. Besides, prevalence rates of extended-spectrum beta-lactamase (ESBL) producing isolates, such as Escherichia coli and Klebsiella pneumoniae, were 29% and 65%, respectively [3]. Bacterial biofilm formation is a significant virulence factor that aids in antibiotic resistance and bacterial survival, especially on medical devices [4]. Seaweeds are considered as promising sources of new antibacterial agents. More than one thousand bioactive components from a marine source, including algal secondary metabolites, have been globally defined as possible antibacterial, antiviral, anti-inflammatory, and anticancer agents [5]. Brown algae are known in the field of medicine and nutrition. Their medical history goes back to time when they were used for treating diarrhea, urinary disorders, and chronic bacterial infections in Europe [6]. Their cell walls comprise a distinct variety of bioactive polysaccharides, as well as fewer amounts of phenolic substances, proteins, and halide compounds such as iodide [7]. The thallus of Hydroclathrus clathratus appears perforated in a sponge resembling form; hence, its Latin name clathratus means latticed, indicating its morphology. The alga is distributed worldwide in warm seas and calm, shallow areas such as Europe, both coasts of Africa, the Pacific Islands, Asia, Australia, North America, and South America, from California through Chile and the Gulf of Mexico [8]. Algal phytochemicals contain functional groups, such as hydroxyl, carboxyl, and amino groups, which are beneficial for the reduction and capping process required to synthesize a stable and robust coating on metal NPs [9]. Scientists recommend algae in biological NP synthesis, due to their high metal uptake capacity and their minimal cost of production, which are golden advantages, compared to other bioreductants [10]. This study aims to screen the phytochemicals of the brown alga Hydroclathrus clathratus (methanol extract and raw powder). Then, we investigate its bioreducing ability of silver nitrate to silver nanoparticles (AgNPs) and explore its biological activity as an antibacterial and antibiofilm agent against a number of pathogenic bacteria, including MDR bacteria.

2 Materials and methods

2.1 Algae collection and preparation

H. clathratus (Figure 1) was collected from the northwest coast of Al-Haraa, Umluj City, Red Seashore, Kingdom of Saudi Arabia, in April 2017. The algae were kept in ice packs in plastic bags containing seawater for preservation. They were then washed and shade dried at room temperature and finely powdered using an electric coffee grinder. The algae were then preserved in tight dark containers in the freezer before use. H. clathratus was identified, according to [11,12].

Figure 1 Hydroclathrus clathratus on the collection site.
Figure 1

Hydroclathrus clathratus on the collection site.

2.2 Crude methanol extraction

H. clathratus (219 g) was saturated three times in 1 L of methanol for 72 h. The mixture was agitated (WNB shaker) to ensure constant agitation during the saturation procedure. Methanol extracts were collected, filtered, and combined. The combined extract was concentrated by evaporating methanol on a rotavapor at ±50°C; after evaporating the solvent, the sample was preserved at room temperature. At the onset of each biological test, a stock solution was prepared at a concentration of 100 mg/mL in 100% DMSO. The extract was then kept in a sterile tube at 4°C until use.

2.3 Raw algal powder solution preparation

To prepare the raw algal powder, 5 g of the powdered algae was added to 100 mL of distilled water for easier handling. The mixture was agitated on a magnetic stirrer for 5 h at room temperature and then filtered. The filtrate was then kept in a sterile dark lid flask at 4°C.

2.4 Qualitative phytochemical screening of algal powder and methanol extract

We studied the chemical compositions of both the algal crude methanol extract and the raw powder by gas-chromatography mass spectroscopy (GC-MS) on the Shimadzu model 2010 plus (Japan). The samples were prepared as follows: 247 mg of raw algal powder was dissolved in 20 mL of 3:1 dichloromethane to methanol; in contrast, 104 mg of algal methanol extract was dissolved in 20 mL of methanol. The samples were then analyzed by GC-MS, according to the following parameters. The MS model QP 2010 ultra and injector model AOC-20i were used and operated in total ion chromatogram scan mode and single ion monitoring ion mode to obtain the retention time of each unidentified compound in the mixture extract samples. After adjustment, we obtained sufficient and adequate separation.

2.5 Biological synthesis of AgNPs

The biological synthesis of AgNPs was conducted after modifying the procedure used by [13]. Algal methanol extract stock (3 mL) and the aqueous solution (3 mL) were added dropwise into a flask containing 22 mL of 1 mM AgNO3 aqueous solution. The flasks were then exposed to heat (50°C) to reduce the reaction time. Color change to brown was the visual assessment of AgNPs’ formation for the algal aqueous solution (AgNPQB); however, due to intensity of the green chlorophyll pigment in the NPs formed by the methanol extract (AgNPCB), it was essential to use UV-vis spectroscopy to confirm their formation.

2.6 Characterization of biosynthesized silver NPs

The obtained AgNPs were first characterized by UV-vis spectroscopy (Libra S60PC) in the range between 350 and 750 nm. The morphological assessment of AgNPs was conducted using both transmission electron microscopy (TEM) [JEM 1400] at 80 kV accelerating voltage and dynamic light scattering (DLS) (Nano ZS zetasizer system [Malvern Instruments]), which was also used to clarify the dispersity of formed NPs. Fourier-transform infrared spectroscopy (FTIR) [PerkinElmer FTIR system spectrum BX] was used to investigate the involvement of functional groups in the formation of AgNPs in the range between 4,000 and 400 cm−1. Lastly, evaluation of the elemental silver percentage was performed by energy-dispersive spectroscopy (EDS) [JSM-6380 LA].

2.7 Antibacterial activity of biologically synthesized AgNPs

Agar well-diffusion assay and minimum bactericidal concentration (MBC) on agar were performed following The National Committee for Clinical Laboratory (2006) standards. The minimum inhibitory concentration (MIC) assay was performed following [14], with a few modifications. The tested concentration range varied from 18 to 0.035 mg/mL. All experiments were repeated three times and evaluated in comparison to the positive and negative controls.

2.8 Tested bacteria and media

The biologically obtained AgNPs were tested against eighteen bacteria, including seven MDR bacteria. Pure cultures of bacterial strains were obtained from the Microbiology laboratory, in Prince Sultan Military Medical City, Riyadh. The bacteria were first cultured on sheep blood agar (Oxoid) before each experiment. Mueller–Hinton agar was used in the agar well-diffusion assay, and 80 µL of tested AgNPs was loaded into 6 mm wells in the agar. Mueller–Hinton Broth was used in the MIC assay and SBA was used in the MBC assay. All tested plates were incubated at 37°C for 18–24 h.

2.9 Biofilm growth and development inhibition assay of biologically synthesized AgNPs

AgNPCB were tested for their antibiofilm ability in triplicate. Six biofilm-forming bacteria were tested (MDR A. baumannii, MDR P. aeruginosa, MRSA, A. baumannii, P. aeruginosa, and S. aureus). The protocol was adapted from [15] with modifications. The assay was performed in a 96-well flat-bottom microplate. The brain–heart infusion broth medium was used. For the biofilm quantitative analysis, we used crystal violet (CV) stain 1% (w/v) aqueous solution. Next, the microplates were destained and examined optically using an ELISA reader (EMax® Endpoint ELISA Microplate Reader) at OD450 nm. The results were averaged, prior to calculating the inhibition percentage using the formula [16]:

(1)Percentageofinhibition(%)=1ATreatedWell450nmAUntreatedcontrol450nm×100

2.10 Statistical analysis

Each test was tested three times for repetitions; means and standard deviations were obtained using Microsoft Excel 16.19.

3 Results

3.1 Qualitative phytochemical screening of algal powder and methanol extract

We were able to separate more than 60 components. The isolated phytochemicals included saturated and unsaturated fatty acids, sugars, carboxylic acid derivatives, triterpenoids, steroids, and other components such as alkenes and phytols (Table 1).

Table 1

Major components present in H. clathratus methanol extract and powder, and their percent relative concentration

ComponentPercent relative concentration (%)
H. clathratus MeOHH. clathratus powder
Hexadecanoic acid21.6721.51
Oleic acid13.1815.32
Octadecanoic acid2.5923.65
Tetradecanoic acid8.687.08
Glyceryl-glycoside2.130
Others51.7532.44

3.2 Characterization of biosynthesized AgNPs

3.2.1 UV-visible spectroscopy (UV-vis)

The confirmation of AgNPs’ formation was assessed visually by a color change. However, due to the intensity of the green pigment in the algal methanol extract, a spectroscopic analysis was required. Biosynthesis of AgNPCB occurred shortly after adding the algal extract (within 1 h), and the highest absorption peak was evident at 411 nm (Figure 2a). In contrast, AgNPQB biosynthesis was monitored for a month; due to the slow formation of AgNPs, the formation of AgNPQB manifested at day 11 and was increased consistently. The highest peak was recorded on the 29th day at 451 nm (Figure 3a). Next, the sample was set for other characteristic techniques and biological tests.

Figure 2 Characterization of biosynthesized AgNPCB by: (a) UV-vis spectroscopy, (b) DLS, (c) EDS of AgNPCB presenting 30% of Ag, (d) TEM imaging, and (e) FTIR of H. clathratus crude methanol extract before (black) and after AgNPCB synthesis (red).
Figure 2

Characterization of biosynthesized AgNPCB by: (a) UV-vis spectroscopy, (b) DLS, (c) EDS of AgNPCB presenting 30% of Ag, (d) TEM imaging, and (e) FTIR of H. clathratus crude methanol extract before (black) and after AgNPCB synthesis (red).

Figure 3 Characterization of biosynthesized AgNPQB using: (a) UV-vis spectroscopy, (b) DLS, (c) EDS of AgNPQB presenting 70% of Ag, (d) TEM imaging, and (e) FTIR of H. clathratus raw powder aqueous solution before (black) and after AgNPQB synthesis (red).
Figure 3

Characterization of biosynthesized AgNPQB using: (a) UV-vis spectroscopy, (b) DLS, (c) EDS of AgNPQB presenting 70% of Ag, (d) TEM imaging, and (e) FTIR of H. clathratus raw powder aqueous solution before (black) and after AgNPQB synthesis (red).

3.2.2 DLS

Zeta size was used to investigate the particle size and distribution of AgNPs. Furthermore, it was used to determine the stability of obtained AgNPs in reference to the polydispersity index (PDI) value. AgNPCB showed an average NP size of 136.9 d.nm and PDI of 0.139 (Figure 2b), implicating the high stability and narrow size distribution of AgNPs. AgNPQB presented an average particle size of 83 d nm and PDI of 0.196 (Figure 3b), signifying its narrow size distribution and high stability.

3.2.3 TEM

TEM was used to study the morphological features such as shape and size of biosynthesized AgNPs. The produced AgNPCB were spherical and polygonal and ranged in size from 7 to 31 nm (Figure 2d). On the contrary, AgNPQB showed a variation in shapes, including spherical, triangle, quadrangular, and rod shapes, and their sizes ranged from 11 to 49 nm (Figure 3d).

3.2.4 EDS

EDS was used to conduct chemical composition analysis using a scanning electron microscope and to further confirm the presence of elemental Ag for verifying the reduction reaction. The analysis of synthesized AgNPs within H. clathratus showed the presence of elemental silver at 2.983 keV (Figures 2 and 3c).

3.2.5 FTIR

FTIR of AgNPCB unveiled a strongly stretched band at a lower frequency (3400.38 cm−1) than the extract before AgNPCB formation (3413.56 cm−1). Sharp bands were apparent at 2924.12 and 2854.96 cm−1, all of which reduced in intensity after AgNPCB formation. A band at 1714.17 cm−1 shifted to a higher frequency (1,725 cm−1) and reduced in intensity. The peaks from 1419.49 to 1646.16 cm−1 might be assigned to the involvement of C═C groups. A band disappeared at 1245.86 cm−1 after AgNPCB production, and a new band emerged in a lower frequency at 1023.61 cm−1 with a higher intensity; this may be a result of Ag bonding with O2 in the C–O group (Figure 2e).

In contrast, AgNPQB showed strongly stretched bands at 3427.22 cm−1, suggesting the hydroxyl group’s involvement in the biosynthesis. The peak at 2928.14 cm−1 is attributed to the presence of aliphatic hydrocarbons. The reduction in the band 1635.12 cm−1 may indicate the involvement of benzene in the reduction of AgNPs. A bending of the peak at 1430.42 cm−1 was also observed with a lower intensity. Furthermore, medium stretching of bands was noted between 1262.32 and 1033.63 cm−1 with an evidence of lower intensity. The reduction in the intensity of the peak at 1033.63 cm−1 is attributed to the C–O group (Figure 3e).

3.3 Antibacterial activity of biologically synthesized AgNPs

3.3.1 Agar well-diffusion assay

To assess the biological activity of synthesized AgNPs, we performed an agar well-diffusion assay. Results are shown in (Table 2) that presents the diverse responses of bacteria to AgNPs.

Table 2

Antibacterial activity of biologically synthesized AgNPCB and AgNPQB

BacteriaInhibition zone (mm)
AgNPCBAgNPQB
MDR Acinetobacter baumannii (MRSTAB) ATCC® BAA179017.2 ± 1.310.0 ± 1.0
ESBLs producing Enterobacter cloacae ATCC® BAA 246809.3 ± 0.6ND
ESBLs producing Escherichia coli*ND10.3 ± 0.6
Klebsiella pneumoniae carbapenemase (KPC) ATCC® BAA 207807.3 ± 5.700.0 ± 0.0
Methicillin-resistant S. aureus (MRSA) ATCC 4330017.0 ± 0.010.3 ± 0.6
MDR Pseudomonas aeruginosa (MRSTPA) ATCC® BAA 210911.8 ± 0.308.8 ± 0.8
Vancomycin-resistant Enterococcus faecium (VRE) ATCC 70022108.3 ± 0.600.0 ± 0.0
A. baumannii ATCC 1960616.7 ± 2.514.3 ± 0.3
Salmonella Typhimurium ATCC 1402813.0 ± 0.911.8 ± 0.8
E. coli ATCC 3521812.0 ± 0.512.2 ± 0.3
K. pneumoniae ATCC® BAA 170611.3 ± 0.609.5 ± 0.5
Enterobacter cloacae ATCC 130478.0 ± 0.011.3 ± 0.6
P. aeruginosa ATCC 2785313.0 ± 0.013.8 ± 1.4
Enterococcus faecalis ATCC 2921200.0 ± 0.000.0 ± 0.0
S. aureus ATCC 2592316.3 ± 0.615.3 ± 0.6
Proteus vulgaris ATCC 491329.3 ± 0.605.3 ± 4.6
Streptococcus pneumoniae ATCC 630511.3 ± 0.6ND
S. pneumoniae*ND00.0 ± 0.0

The diameter of the well (6 mm) was calculated within the zone of inhibition. The results shown are recorded as means ± standard deviation (SD). * – patient isolate. ND – no data.

3.3.2 Microtiter MIC and MBC

The microtiter MIC and MBC assays showed various values depending on the tested bacteria with different responses to each of the biosynthesized AgNPs (Table 3). Some bacteria exhibited the same MIC and MBC values, indicating that the same concentration was both bacteriostatic and bactericidal.

Table 3

MIC and MBC of biologically synthesized AgNPCB and AgNPQB

BacteriaAgNPCB (mg/mL)AgNPQB (mg/mL)
MICMBCMICMBC
MDR A. baumannii1.125 ± 0.01.50 ± 0.64.50 ± 0.04.50 ± 0.0
ESBLs producing E. cloacae2.250 ± 0.06.00 ± 2.6NDND
ESBLs producing E. coli*NDND9.00 ± 0.09.00 ± 0.0
K. pneumoniae carbapenemase4.500 ± 0.0>18 ± 0.0>18 ± 0.0>18 ± 0.0
MRSA2.250 ± 0.09.00 ± 7.89.00 ± 0.018.0 ± 0.0
MDR P. aeruginosa0.938 ± 0.32.25 ± 0.04.50 ± 0.09.00 ± 0.0
A. baumannii0.938 ± 0.31.500 ± 0.60.938 ± 0.321.125 ± 0.00
Salmonella Typhimurium1.875 ± 0.62.250 ± 0.02.250 ± 0.004.500 ± 0.00
E. coli0.938 ± 0.31.125 ± 0.01.125 ± 0.001.125 ± 0.00
K. pneumoniae4.500 ± 0.09.000 ± 0.07.500 ± 2.60>18 ± 0.0
E. cloacae3.750 ± 1.34.500 ± 0.00.938 ± 0.321.688 ± 0.97
P. aeruginosa0.938 ± 0.31.125 ± 0.03.750 ± 1.303.750 ± 1.30
Staphylococcus aureus1.125 ± 0.02.250 ± 0.01.875 ± 0.653.750 ± 1.30
Proteus vulgaris1.875 ± 0.6ND4.500 ± 0.004.500 ± 0.00

Results are shown as means ± SD. ND – no data.

3.3.3 Antibiofilm activity of AgNPs synthesized using H. clathratus

The CV staining assay of produced biofilm investigated the antibiofilm growth and development activity of AgNPs. As shown in (Table 4), all bacterial biofilms were resistant; however, MRSA was highly susceptible to AgNPCB.

Table 4

Antibiofilm growth and development activity of AgNPCB

Tested bacteriaBiofilm inhibition percentage (%)
AgNPs synthesized using H. clathratus
Conc. (100%)Conc. (50%)
MDR Acinetobacter baumannii1.01.5
MRSA98.999.1
MDR Pseudomonas aeruginosa4.34.6
Acinetobacter baumannii2.43.0
Staphylococcus aureus00.5
Pseudomonas aeruginosa1.00.9

Conc. – concentration. All data were averaged before calculating the inhibition percentage.

4 Discussion

In the present study, phytochemicals from the alga H. clathratus were screened and used for the first time as a bioreductant to biosynthesize AgNPs. Producing inorganic AgNPs using “green” techniques is known to be eco-friendly, fast, and efficient. Other merits include their stability, endurance to high temperature, and low toxicity to humans, which can benefit medical applications [9].

The phytochemical screening using GC-MS identified saturated and unsaturated fatty acids, mostly, carboxylic acids, sugars, steroids, phytols, and other products. These components attributed to having an antibacterial activity or suggested as a reducing agent in the green synthesis of NPs [9]. Also, the detected fatty acids in algal extracts such as: palmitic, palmitoleic, stearic, oleic, and linoleic acids have a role in destroying the bacterial cell wall structure and function. They act as anionic surfactants, thus exhibiting their antibacterial and antioxidant activity [16].

The obtained AgNPs were characterized, and their biological activity was investigated against a variety of bacteria, including some MDR bacteria. We confirmed the formation of AgNPs, first using UV-vis spectroscopy showing peaks between 400 and 450 nm, specifically at 411 and 451 nm for AgNPCB and AgNPQB, respectively. Thus, this signifies the surface plasmon resonance of silver, which is similar to [17] and other studies that used algae and plants as reducing agents [18,19].

DLS and TEM analyses were performed to evaluate the morphological properties and stability of AgNPs. AgNPCB and AgNPQB varied in size and shape (spherical, quadrangular, triangular, polygonal, and rods). Remarkably, biosynthesis using the algal powder produced smaller particles relative to those formed using the extract, albeit slowly. There was a noticeable inconsistency in the size of AgNPs in both DLS and TEM. To illustrate, DLS measures the hydrodynamic size of the particles involving its capping phytochemicals from the algal extract, while TEM measures the exact geometric size of NPs [20,21]. Despite these inconsistencies, our findings are mostly consistent with those of other researchers and are deemed acceptable, based on the assumption that the discrepancies are due to technical variability associated with the different equipment used rather than measurement errors.

EDS verified the presence of elemental silver in all nanosolutions. The optical absorbance at 3 keV is attributed to plasmon resonance of the metallic silver nanocrystals and is known as the Ag region [22]. This result is consistent with that of Shaik et al. [23], which used Salvadora persica L. root extract (Miswak) in the green synthesis of AgNPs.

FTIR was used to confirm the involvement of the algal functional groups in biomolecules during the reduction reaction [24]. The extracts were tested before and after the formation of AgNPs to compare the occurring shift in the resulting peaks. Use of metal salts to synthesize NPs requires a stabilizer against the van der Waals forces of attraction to avoid coagulation [25]. FTIR results accentuate the contribution of the hydroxyl group (O–H bond) at 3400.38 and 3427.22 cm−1 after AgNPCB and AgNPQB synthesis, respectively. The hydroxyl group particularly has been proven to reduce the metal ions of silver to its atom “nano” form and conduct stability for formed NPs, hence its ability to increase oxygen bonding. These findings are compatible with those observed in earlier studies [26,27].

Hydroclathrus clathratus has been used as an antitumor, antioxidant, and antibacterial agent [28,29,30]; yet, to the best of our knowledge, there are no published studies on the biosynthesis of NPs from this algal species. Algae are considered as effective bio-nanofactories for synthesizing metallic NPs; hence, they are abundantly available, and both dead and live biomass can be successfully used in the production of metallic NPs [31]. There are two acceptable antibacterial actions of AgNPs: contact killing by infiltrating bacterial cells and Ag+ ion-mediated killing by generating reactive oxygen species (ROS) [32]. Oves et al. [33] used the fluorescent probe 2,7-dichlorofluorescein diacetate dyes to detect ROS production by AgNPs inside the bacterial cells. Results showed that free radicals’ production in the media was associated with increased concentrations of AgNPs and incubation time. Many studies have demonstrated that bio-AgNP activity is concentration-dependent. More recent evidence proposes that bacterial aggregation and physiology are essential determinants that define the predominance of one or several of the proposed mechanisms for the AgNPs’ antibacterial activity [34]. Moreover, studies have demonstrated that the relatively large surface area of smaller AgNPs facilitates the release of more silver ions, which penetrate the bacterial cell membrane leading to its death [35,36].

The in vitro biological tests against bacteria exhibited varied responses to the AgNPs, which were expressed by the diameter of the inhibition zone. AgNPs synthesized by algal methanol extracts were more effective, compared to the raw powder aqueous solution against bacteria. Remarkably, A. baumannii and S. aureus, both the sensitive and resistant strains, were the most affected by the algal methanol extracts, compared to other bacteria. Alavi et al. [37] studied the antibacterial activities of Ag, Cu, TiO2, ZnO, and Fe3O4 NPs biologically synthesized using Protoparmeliopsis muralis lichen aqueous extract against MRSA, E. coli, and P. aeruginosa. The highest antibacterial activity was noticed with 0.1 M concentration of AgNPs against P. aeruginosa, MRSA, and E. coli, respectively. In contrast, AgNPQB was more effective against nonresistant S. aureus, A. baumannii, and P. aeruginosa. Studies have shown that Gram-positive bacteria are more susceptible to AgNPs, compared to Gram-negative bacteria due to their structural differences. Contradicting earlier findings [38,39], we found no biased antibacterial action against either Gram-positive or Gram-negative bacteria, which could be attributed to the charge difference between the AgNPs and bacterial cells [32].

Previous research work revealed the difficulty in biofilm growth and development inhibition, compared to cell attachment inhibition [15]. In this study, biofilm growth and development inhibition assay were used to evaluate the antibiofilm activity of AgNPs. We tested the antibiofilm activity of AgNPCB against selected biofilm-forming bacteria in two concentrations. There were no notable differences between tested concentrations, and they profoundly inhibited the biofilm of MRSA with 99% inhibition. A study investigated the antibiofilm effect of bio-AgNPs fabricated using the Artemisia scoparia plant as a bioreductant and compared it to that of commercial AgNPs against 50 strains of S. aureus. They assessed this effect on bacterial biofilm at a molecular level, specifically on icaABCD genes, which are essential for biofilm formation. The results registered a more notable reduction and induction in icaA and icaR gene expression with the sub-MIC doses of biosynthetic AgNP contrasted to commercial AgNP [40]. Rolim et al. [41] synthesized AgNPs using the fungus Stereum hirsutum and two plant extracts (green tea and dill) and studied their antibiofilm activity against several bacterial strains of medical interest. MDR P. aeruginosa was highly susceptible to the AgNPs synthesized using S. hirsutum with 97% inhibition. Our findings, while dissatisfactory, further implicate the cost of bacterial antibiotics’ resistance in its fitness and virulence in MRSA specifically.

A study suggested using nanotechnology to coat surgical devices and medical implants to control biofilm formation because NPs are capable of breaching the extracellular polymeric substance layer and the bacterial membrane of both Gram-positive and Gram-negative bacteria [42]. Even though we did not find this association with all tested bacteria, there are still controversies on whether the antibiotics’ resistance to bacteria contributes positively or negatively to biofilm formation [43]. We recommend testing the effect of AgNPCB against MDR bacteria and on different stages of biofilm formation to comprehend their antibiofilm activity fully in the future.

5 Conclusions

This study has explored the capacity of the brown alga H. clathratus to produce NPs extracellularly following a rapid and biological approach. Different techniques were used to characterize the produced AgNPs and obtain a thorough background for the future application of formed AgNPs. Our research work has further proven the activity of biosynthesized AgNPs as antibacterial and antibiofilm agents with room for improvement. We also introduced many questions in need of further investigation regarding the consequences of drug resistance on bacterial fitness and bacterial biofilm formation, which may help in developing antibacterial/antibiofilm drugs and improving the fields of biotechnology and health altogether.

Acknowledgments

The authors would like to thank the Deanship of Scientific Research in King Saud University for funding and supporting this research work through the initiative of DSR Graduate Students Research Support (GSR). The authors would also like to acknowledge the help and advice provided by Prof. Nawal M. Almusayeib and Prof. Musarat Amina, from King Saud University, and Prof. Manal Awad, from King Abdullah Institute for Nanotechnology. Also, the authors thank Dr. Aref Elmubarak from the Plant Protection Department at King Saud University for performing the phytochemical screening of the algal samples.

Appendix

Table A1

Phytochemicals identified in the MeOH extract and powder of H. clathratus

RTCompound nameSynonym
Phytocomponents in the MeOH extract
Saturated fatty acids
24.135n-Tridecanoic acidTridecanoic acid
25.885Tetradecanoic acidMyristic acid
27.115/29.185Hexadecanoic acidPalmitic acid
27.48n-Pentadecanoic acidNS
28.64/28.905Palmitelaidic acid9-Hexadecenoic acid
28.74cis-9-Hexadecenoic acidPalmitoleic acid
31.98Octadecanoic acidStearic acid
34.68Eicosanoic acidArachidic acid
Unsaturated fatty acids
29.9059-Octadecenoic acidElaidic acid
30.17cis-10-Heptadecenoic acid10Z-Heptadecenoic acid
31.5559,12-Octadecadienoic acid (Z,Z)-Linoleic acid
31.695Oleic acidOmega 9
33.78Arachidonic acidcis-5,8,11,14-Eicosatetraenoic acid
33.88cis-5,8,11,14,17-Eicosapentaenoic acidEicosapentaenoic acid
34.179-Decenoic acidCaproleic acid
Sugars
27.055Galactopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)-,.beta.-d-Galactopyranose
27.6551,5-Anhydro-d-sorbitolGlucitol; (sugar alcohol)
33.54Glyceryl-glycosideNS
38.6152-Monostearin2-Stearoylglycerol
Carboxylic acids (derivatives)
6.38Formamide, N,N-diethyl-Formamide
Steroids
14.715Glycerol(Glycerin)
Others
25.015Borneol(−)-Borneol (bicyclic monoterpenoids)
25.655/26.383,7,11,15-Tetramethyl-2-hexadecen-1-olPhytol
36.695Hexadecanoic acid, 2,3-bis[(trimethylsilyl)oxy]propyl esterNS
39.02Octadecanoic acid, 2,3-bis[(trimethylsilyl)oxy]propyl esterNS
RTCompound nameSynonym
Phytocomponents in the powder of H. clathratus
Saturated fatty acids
27.47n-Pentadecanoic acidNS
27.71Trimethylsilyl ether of glucitolGlucitol; sorbitol (sugar alcohol)
29.05Hexadecanoic acidPalmitic acid
31.965Octadecanoic acidStearic acid
34.67Eicosanoic acidArachidonic acid
Unsaturated fatty acids
28.625n-Tridecanoic acidTridecanoic acid
28.725cis-9-Hexadecenoic acidPalmitoleic acid
28.885Palmitelaidic acid9-Hexadecenoic acid
30.16cis-10-Heptadecenoic acid10Z-Heptadecenoic acid
31.549,12-Octadecadienoic acid (Z,Z)-Linoleic acid
31.61/31.705Oleic acidOmega 9
33.765Arachidonic acidcis-5,8,11,14-Eicosatetraenoic acid
33.87cis-5,8,11,14,17-Eicosapentaenoic acidEicosapentaenoic acid
35.4Oleanitrile acid; oleic acid with ammoniaNS
Sugars
38.6052-Monostearin2-Stearoylglycerol
39.38N-Acetyl-d-glucosamine, tetrakis(trimethylsilyl) ether, benzyloxime (isomer 1)NS
Carboxylic acid
39.525Tetracosanoic acidLignoceric acid
Steroids
45.85524-Nor-22,23-methylenecholest-5-en-3.beta.-ol(Sterol)
Others
7.1252,3,3-Trimethyl-, 1-buteneAlkene
25.645/26.373,7,11,15-Tetramethyl-2-hexadecen-1-olPhytol
36.69Hexadecanoic acid, 2,3-bis[(trimethylsilyl)oxy]propyl esterNS
38.705Eicosanoic acid, 2,3-bis[(trimethylsilyl)oxy]propyl esterNS

RT – retention time. NS – no synonyms. Synonyms were obtained via NIST, PubChem, ChEBI, and HMDB.

  1. Author contributions: M. M. A. and N. M. A. prepared the research design and supervision; R. R. A. performed experiments and wrote the manuscript.

References

[1] Baptista PV, McCusker MP, Carvalho A, Ferreira DA, Mohan NM, Daniela AF, et al. Nano-strategies to fight multidrug resistant bacteria—“a battle of the titans”. Front Microbiol. 2018;9:1441.10.3389/fmicb.2018.01441Search in Google Scholar

[2] Al-Hajoj S, Varghese B, Shoukri MM, Al-Omari R, Al-Herbwai M, AlRabiah F, et al. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the First National Survey. Antimicrob Agents Chemother. 2013;57(5):2161–66.10.1128/AAC.02403-12Search in Google Scholar

[3] Zowawi HM, Balkhy HH, Walsh TR, Paterson DL. β-Lactamase production in key Gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev. 2013;26(3):361–80.10.1128/CMR.00096-12Search in Google Scholar

[4] Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322–32.10.1016/j.ijantimicag.2009.12.011Search in Google Scholar

[5] Shannon E, Abu-Ghannam N. Antibacterial derivatives of marine algae: an overview of pharmacological mechanisms and applications. Mar Drugs. 2016;14(4):81.10.3390/md14040081Search in Google Scholar

[6] Khan AR, Qari R. Antibacterial activities of brown seaweed Sargassum boveanum (J. Ag.) against diarrhea along the Coast of Karachi, Pakistan. J Environ Res Dev. 2012;6(3A):753–7.Search in Google Scholar

[7] Torode TA, Marcus SE, Jam M, Tonon T, Blackburn RS, Herve C, et al. Monoclonal antibodies directed to fucoidan preparations from brown algae. PLoS One. 2015;10(2):e0118366.10.1371/journal.pone.0118366Search in Google Scholar

[8] Pereira L. Seaweed flora of the European North Atlantic and Mediterranean. In: Kim SK, editor. Springer Handbook of Marine Biotechnology. Berlin: Springer Berlin Heidelberg; 2015.10.1007/978-3-642-53971-8_6Search in Google Scholar

[9] El-Sheekh MM, El-Kassas HY. Algal production of nano-silver and gold: Their antimicrobial and cytotoxic activities: a review. J Genet Eng Biotechnol. 2016;14(2):299–310.10.1016/j.jgeb.2016.09.008Search in Google Scholar

[10] Davis TA, Volesky B, Mucci A. A review of the biochemistry of heavy metal biosorption by brown algae. Water Res. 2003;37(18):4311–30.10.1016/S0043-1354(03)00293-8Search in Google Scholar

[11] Aleem AA. The marine algae of Alexandria. Alexandria: Egypt. Univ. Alexandria; 1993.Search in Google Scholar

[12] Coppejans E, Leliaert F, Dargent O, Gunasekara R, De Clerck O. Sri Lankan Seaweeds – Methodologies and field guide to the dominant species. Brussels: Belgian Development Cooperation; 2009.Search in Google Scholar

[13] Rajeshkumar S, Kannan C, Annadurai G. Green synthesis of silver nanoparticles using marine brown algae Turbinaria conoides and its antibacterial activity. Int J Pharm Bio Sci. 2012;3(4):502–10.Search in Google Scholar

[14] Xie JL, Singh-Babak SD, Cowen LE. Minimum inhibitory concentration (MIC) assay for antifungal drugs. Bio Protoc. 2012;2(20):e252.10.21769/BioProtoc.252Search in Google Scholar

[15] Bazargani MM, Rohloff J. Antibiofilm activity of essential oils and plant extracts against Staphylococcus aureus and Escherichia coli biofilms. Food Control. 2016;61:156–64.10.1016/j.foodcont.2015.09.036Search in Google Scholar

[16] Karimi E, Jaafar HZ, Ghasemzadeh A, Ebrahimi M. Fatty acid composition, antioxidant and antibacterial properties of the microwave aqueous extract of three varieties of Labisia pumila Benth. Biol Res. 2015;48(1):9.10.1186/0717-6287-48-9Search in Google Scholar PubMed PubMed Central

[17] Rajoriya P. Green synthesis of silver nanoparticles, their characterization and antimicrobial potential [PhD thesis]. Sam Higginbottom University of Agriculture Technology and Sciences, India, 2017.Search in Google Scholar

[18] Patra JK, Baek KH. Antibacterial activity and synergistic antibacterial potential of biosynthesized silver nanoparticles against foodborne pathogenic bacteria along with its anticandidal and antioxidant effects. Front Microbiol. 2017;8:167.10.3389/fmicb.2017.00167Search in Google Scholar PubMed PubMed Central

[19] Khalifa KS, Ragaa AH, Hanafy AH. Antitumor activity of silver nanoparticles biosynthesized by micro algae. J Chem Pharm Res. 2016;8(3):1–6.Search in Google Scholar

[20] Tomaszewska E, Soliwoda K, Kadziola K, Tkacz-Szczesna B, Celichowski G, Cichomski M, et al. Detection limits of DLS and UV-Vis spectroscopy in characterization of polydisperse nanoparticles colloids. J Nanomater. 2013;2013:10.10.1155/2013/313081Search in Google Scholar

[21] Chartarrayawadee W, Charoensin P, Saenma J, Rin T, Khamai P, Nasomjai P, et al. Green synthesis and stabilization of silver nanoparticles using Lysimachia foenum-graecum Hance extract and their antibacterial activity. Green Proc Synth. 2020;9(1):107–18.10.1515/gps-2020-0012Search in Google Scholar

[22] Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria. Nanomed Nanotechnol Biol Med. 2010;6(1):103–9.10.1016/j.nano.2009.04.006Search in Google Scholar PubMed

[23] Shaik M, Albalawi GH, Khan ST, Khan M, Adil SF, Kuniyil M, et al. “Miswak” based green synthesis of silver nanoparticles: evaluation and comparison of their microbicidal activities with the chemical synthesis. Molecules. 2016;21(11):1478.10.3390/molecules21111478Search in Google Scholar PubMed PubMed Central

[24] Faghihzadeh F, Anaya NM, Schifman LA, Oyanedel-Craver V. Fourier transform infrared spectroscopy to assess molecular-level changes in microorganisms exposed to nanoparticles. Nanotechnol Environ Eng. 2016;1(1):1.10.1007/s41204-016-0001-8Search in Google Scholar

[25] Sivagnanam SP, Getachew AT, Choi JH, Park YB, Woo HC, Chun BS. Green synthesis of silver nanoparticles from deoiled brown algal extract via Box-Behnken based design and their antimicrobial and sensing properties. Green Proc Synth. 2017;6(2):147–60.Search in Google Scholar

[26] Wang Z, Xu C, Zhao M, Zhao C. One-pot synthesis of narrowly distributed silver nanoparticles using phenolic-hydroxyl modified chitosan and their antimicrobial activity. RSC Adv. 2014;4(87):47021–30.10.1039/C4RA06908KSearch in Google Scholar

[27] Guerrini L, Alvarez-Puebla RA, Pazos-Perez N. Surface modifications of nanoparticles for stability in biological fluids. Materials. 2018;11(7):1154.10.3390/ma11071154Search in Google Scholar PubMed PubMed Central

[28] Vimala T, Poonghuzhali T. In vitro antimicrobial activity of solvent extracts of marine brown alga, Hydroclathrus clathratus (C. Agardh) M. Howe from Gulf of Mannar. J Appl Pharm Sci. 2017;7(04):157–62.Search in Google Scholar

[29] Kelman D, Posner EK, McDermid KJ, Tabandera NK, Wright PR, Wright AD. Antioxidant activity of Hawaiian marine algae. Mar Drugs. 2012;10(2):403–16.10.3390/md10020403Search in Google Scholar PubMed PubMed Central

[30] Wang H, Chiu LC, Ooi VE, Ang PO. A potent antitumor polysaccharide from the edible brown seaweed Hydroclathrus clathratus. Bot Mar. 2010;53(3):265–74.10.1515/BOT.2010.029Search in Google Scholar

[31] LewisOscar F, Vismaya S, Arunkumar M, Thajuddin N, Dhanasekaran D, Nithya C. Algal nanoparticles: synthesis and biotechnological potentials. Algae-organisms for imminent. Biotechnology. 2016;7:157–82.Search in Google Scholar

[32] Yun’an Qing LC, Li R, Liu G, Zhang Y, Tang X, Wang J, et al. Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies. Int J Nanomed. 2018;13:3311.10.2147/IJN.S165125Search in Google Scholar PubMed PubMed Central

[33] Oves M, Rauf MA, Hussain A, Qari HA, Khan AP, Muhammad P, et al. Antibacterial silver nanomaterial synthesis from Mesoflavibacter zeaxanthinifaciens and targeting biofilm formation. Front Pharmacol. 2019;10:801.10.3389/fphar.2019.00801Search in Google Scholar PubMed PubMed Central

[34] Rodriguez-Serrano C, Guzman-Moreno J, Angeles-Chavez C, Rodriguez-Gonzalez V, Ortega-Sigala JJ, Ramirez-Santoyo RM, et al. Biosynthesis of silver nanoparticles by Fusarium scirpi and its potential as antimicrobial agent against uropathogenic Escherichia coli biofilms. PLoS One. 2020;15(3):e0230275.10.1371/journal.pone.0230275Search in Google Scholar PubMed PubMed Central

[35] Chowdhury S, Basu A, Kundu S. Green synthesis of protein capped silver nanoparticles from phytopathogenic fungus Macrophomina phaseolina (Tassi) Goid with antimicrobial properties against multidrug-resistant bacteria. Nanoscale Res Lett. 2014;9(1):1–11.10.1186/1556-276X-9-365Search in Google Scholar PubMed PubMed Central

[36] Raza MA, Kanwal Z, Rauf A, Sabri AN, Riaz S, Naseem S. Size-and shape-dependent antibacterial studies of silver nanoparticles synthesized by wet chemical routes. Nanomaterials. 2016;6(4):74.10.3390/nano6040074Search in Google Scholar PubMed PubMed Central

[37] Alavi M, Karimi N, Valadbeigi T. Antibacterial, antibiofilm, antiquorum sensing, antimotility, and antioxidant activities of green fabricated Ag, Cu, TiO2, ZnO, and Fe3O4 NPs via protoparmeliopsis muralis lichen aqueous extract against multi-drug-resistant bacteria. ACS Biomater Sci Eng. 2019;5(9):4228–43.10.1021/acsbiomaterials.9b00274Search in Google Scholar PubMed

[38] Chatterjee T, Chatterjee BK, Majumdar D, Chakrabarti P. Antibacterial effect of silver nanoparticles and the modeling of bacterial growth kinetics using a modified Gompertz model. BBA-Gen Subjects. 2015;1850(2):299–306.10.1016/j.bbagen.2014.10.022Search in Google Scholar PubMed

[39] Al-Sharqi A, Apun K, Vincent M, Kanakaraju D, Bilung LM. Enhancement of the antibacterial efficiency of silver nanoparticles against Gram-positive and Gram-negative bacteria using blue laser light. Int J Photoenergy. 2019;2019:12.10.1155/2019/2528490Search in Google Scholar

[40] Moulavi P, Noorbazargan H, Dolatabadi A, Foroohimanjili F, Tavakoli Z, Mirzazadeh S, et al. Antibiofilm effect of green engineered silver nanoparticles fabricated from Artemisia scoporia extract on the expression of icaA and icaR genes against multidrug-resistant Staphylococcus aureus. J Basic Microbiol. 2019;59(7):701–12.10.1002/jobm.201900096Search in Google Scholar PubMed

[41] Rolim WR, Lamilla C, Pieretti JC, Díaz M, Tortella GR, Diez MC, et al. Comparison of antibacterial and antibiofilm activities of biologically synthesized silver nanoparticles against several bacterial strains of medical interest. Energy Ecol Environ. 2019;4(4):143–59.10.1007/s40974-019-00123-8Search in Google Scholar

[42] LewisOscar F, MubarakAli D, Nithya C, Priyanka R, Gopinath V, Alharbi NS, et al. One pot synthesis and anti-biofilm potential of copper nanoparticles (CuNPs) against clinical strains of Pseudomonas aeruginosa. Biofouling. 2015;31(4):379–91.10.1080/08927014.2015.1048686Search in Google Scholar PubMed

[43] Cepas V, López Y, Munoz E, Rolo D, Ardanuy C, Martí S, et al. Relationship between biofilm formation and antimicrobial resistance in Gram-negative bacteria. Microb Drug Resist. 2019;25(1):72–9.10.1089/mdr.2018.0027Search in Google Scholar PubMed

Received: 2020-04-22
Revised: 2020-06-20
Accepted: 2020-06-28
Published Online: 2020-08-07

© 2020 Raghad R. Alzahrani et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Obituary for Prof. Dr. Jun-ichi Yoshida
  2. Regular Articles
  3. Optimization of microwave-assisted manganese leaching from electrolyte manganese residue
  4. Crustacean shell bio-refining to chitin by natural deep eutectic solvents
  5. The kinetics of the extraction of caffeine from guarana seed under the action of ultrasonic field with simultaneous cooling
  6. Biocomposite scaffold preparation from hydroxyapatite extracted from waste bovine bone
  7. A simple room temperature-static bioreactor for effective synthesis of hexyl acetate
  8. Biofabrication of zinc oxide nanoparticles, characterization and cytotoxicity against pediatric leukemia cell lines
  9. Efficient synthesis of palladium nanoparticles using guar gum as stabilizer and their applications as catalyst in reduction reactions and degradation of azo dyes
  10. Isolation of biosurfactant producing bacteria from Potwar oil fields: Effect of non-fossil fuel based carbon sources
  11. Green synthesis, characterization and photocatalytic applications of silver nanoparticles using Diospyros lotus
  12. Dielectric properties and microwave heating behavior of neutral leaching residues from zinc metallurgy in the microwave field
  13. Green synthesis and stabilization of silver nanoparticles using Lysimachia foenum-graecum Hance extract and their antibacterial activity
  14. Microwave-induced heating behavior of Y-TZP ceramics under multiphysics system
  15. Synthesis and catalytic properties of nickel salts of Keggin-type heteropolyacids embedded metal-organic framework hybrid nanocatalyst
  16. Preparation and properties of hydrogel based on sawdust cellulose for environmentally friendly slow release fertilizers
  17. Structural characterization, antioxidant and cytotoxic effects of iron nanoparticles synthesized using Asphodelus aestivus Brot. aqueous extract
  18. Phase transformation involved in the reduction process of magnesium oxide in calcined dolomite by ferrosilicon with additive of aluminum
  19. Green synthesis of TiO2 nanoparticles from Syzygium cumini extract for photo-catalytic removal of lead (Pb) in explosive industrial wastewater
  20. The study on the influence of oxidation degree and temperature on the viscosity of biodiesel
  21. Prepare a catalyst consist of rare earth minerals to denitrate via NH3-SCR
  22. Bacterial nanobiotic potential
  23. Green synthesis and characterization of carboxymethyl guar gum: Application in textile printing technology
  24. Potential of adsorbents from agricultural wastes as alternative fillers in mixed matrix membrane for gas separation: A review
  25. Bactericidal and cytotoxic properties of green synthesized nanosilver using Rosmarinus officinalis leaves
  26. Synthesis of biomass-supported CuNi zero-valent nanoparticles through wetness co-impregnation method for the removal of carcinogenic dyes and nitroarene
  27. Synthesis of 2,2′-dibenzoylaminodiphenyl disulfide based on Aspen Plus simulation and the development of green synthesis processes
  28. Catalytic performance of the biosynthesized AgNps from Bistorta amplexicaule: antifungal, bactericidal, and reduction of carcinogenic 4-nitrophenol
  29. Optical and antimicrobial properties of silver nanoparticles synthesized via green route using honey
  30. Adsorption of l-α-glycerophosphocholine on ion-exchange resin: Equilibrium, kinetic, and thermodynamic studies
  31. Microwave-assisted green synthesis of silver nanoparticles using dried extracts of Chlorella vulgaris and antibacterial activity studies
  32. Preparation of graphene oxide/chitosan complex and its adsorption properties for heavy metal ions
  33. Green synthesis of metal and metal oxide nanoparticles from plant leaf extracts and their applications: A review
  34. Synthesis, characterization, and electrochemical properties of carbon nanotubes used as cathode materials for Al–air batteries from a renewable source of water hyacinth
  35. Optimization of medium–low-grade phosphorus rock carbothermal reduction process by response surface methodology
  36. The study of rod-shaped TiO2 composite material in the protection of stone cultural relics
  37. Eco-friendly synthesis of AuNPs for cutaneous wound-healing applications in nursing care after surgery
  38. Green approach in fabrication of photocatalytic, antimicrobial, and antioxidant zinc oxide nanoparticles – hydrothermal synthesis using clove hydroalcoholic extract and optimization of the process
  39. Green synthesis: Proposed mechanism and factors influencing the synthesis of platinum nanoparticles
  40. Green synthesis of 3-(1-naphthyl), 4-methyl-3-(1-naphthyl) coumarins and 3-phenylcoumarins using dual-frequency ultrasonication
  41. Optimization for removal efficiency of fluoride using La(iii)–Al(iii)-activated carbon modified by chemical route
  42. In vitro biological activity of Hydroclathrus clathratus and its use as an extracellular bioreductant for silver nanoparticle formation
  43. Evaluation of saponin-rich/poor leaf extract-mediated silver nanoparticles and their antifungal capacity
  44. Propylene carbonate synthesis from propylene oxide and CO2 over Ga-Silicate-1 catalyst
  45. Environmentally benevolent synthesis and characterization of silver nanoparticles using Olea ferruginea Royle for antibacterial and antioxidant activities
  46. Eco-synthesis and characterization of titanium nanoparticles: Testing its cytotoxicity and antibacterial effects
  47. A novel biofabrication of gold nanoparticles using Erythrina senegalensis leaf extract and their ameliorative effect on mycoplasmal pneumonia for treating lung infection in nursing care
  48. Phytosynthesis of selenium nanoparticles using the costus extract for bactericidal application against foodborne pathogens
  49. Temperature effects on electrospun chitosan nanofibers
  50. An electrochemical method to investigate the effects of compound composition on gold dissolution in thiosulfate solution
  51. Trillium govanianum Wall. Ex. Royle rhizomes extract-medicated silver nanoparticles and their antimicrobial activity
  52. In vitro bactericidal, antidiabetic, cytotoxic, anticoagulant, and hemolytic effect of green-synthesized silver nanoparticles using Allium sativum clove extract incubated at various temperatures
  53. The green synthesis of N-hydroxyethyl-substituted 1,2,3,4-tetrahydroquinolines with acidic ionic liquid as catalyst
  54. Effect of KMnO4 on catalytic combustion performance of semi-coke
  55. Removal of Congo red and malachite green from aqueous solution using heterogeneous Ag/ZnCo-ZIF catalyst in the presence of hydrogen peroxide
  56. Nucleotide-based green synthesis of lanthanide coordination polymers for tunable white-light emission
  57. Determination of life cycle GHG emission factor for paper products of Vietnam
  58. Parabolic trough solar collectors: A general overview of technology, industrial applications, energy market, modeling, and standards
  59. Structural characteristics of plant cell wall elucidated by solution-state 2D NMR spectroscopy with an optimized procedure
  60. Sustainable utilization of a converter slagging agent prepared by converter precipitator dust and oxide scale
  61. Efficacy of chitosan silver nanoparticles from shrimp-shell wastes against major mosquito vectors of public health importance
  62. Effectiveness of six different methods in green synthesis of selenium nanoparticles using propolis extract: Screening and characterization
  63. Characterizations and analysis of the antioxidant, antimicrobial, and dye reduction ability of green synthesized silver nanoparticles
  64. Foliar applications of bio-fabricated selenium nanoparticles to improve the growth of wheat plants under drought stress
  65. Green synthesis of silver nanoparticles from Valeriana jatamansi shoots extract and its antimicrobial activity
  66. Characterization and biological activities of synthesized zinc oxide nanoparticles using the extract of Acantholimon serotinum
  67. Effect of calcination temperature on rare earth tailing catalysts for catalytic methane combustion
  68. Enhanced diuretic action of furosemide by complexation with β-cyclodextrin in the presence of sodium lauryl sulfate
  69. Development of chitosan/agar-silver nanoparticles-coated paper for antibacterial application
  70. Preparation, characterization, and catalytic performance of Pd–Ni/AC bimetallic nano-catalysts
  71. Acid red G dye removal from aqueous solutions by porous ceramsite produced from solid wastes: Batch and fixed-bed studies
  72. Review Articles
  73. Recent advances in the catalytic applications of GO/rGO for green organic synthesis
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/gps-2020-0043/html
Scroll to top button